The World Health Organization (WHO) has issued a renewed call for heightened vigilance and preventative measures across the Americas in response to a concerning increase in yellow fever cases. Recent outbreaks have extended beyond historically affected regions, raising concerns about broader public health impacts. This resurgence underscores the ongoing threat posed by this preventable, yet potentially deadly, viral disease.
Yellow fever, transmitted by mosquitoes, is endemic in tropical areas of Africa and South and Central America. While a highly effective vaccine exists, gaps in vaccination coverage and changing environmental factors are contributing to the observed increase in infections. The WHO emphasizes that the potential for international spread remains a significant concern for global health security.
Recent Surge in Cases
According to reports from the Pan American Health Organization (PAHO) and the WHO, 346 confirmed human cases of yellow fever were recorded in seven countries across the Americas during 2025, resulting in 143 deaths. This represents a 5.6-fold increase compared to the 61 cases confirmed in 2024. Early data from 2026, covering the first seven epidemiological weeks (January-February), indicates 34 confirmed cases and 15 deaths.
The countries currently reporting cases include Bolivia (1 death), Colombia (25 cases, including 13 deaths), Peru (2 cases), and Venezuela (6 cases, including 1 death). In 2025, the distribution of cases was as follows: Bolivia (8 cases, 2 deaths), Brazil (120 cases, 48 deaths), Colombia (125 cases, 46 deaths), Ecuador (11 cases, 8 deaths), Guyana (1 death), Peru (49 cases, 19 deaths), and Venezuela (32 cases, 19 deaths).
Understanding the Risks
Yellow fever is a viral hemorrhagic disease transmitted by infected mosquitoes, primarily those that bite during the day. The disease is categorized into phases, with initial symptoms resembling the flu – fever, headache, muscle aches, nausea, and vomiting. These symptoms typically subside within three to four days. However, approximately 15% of individuals develop a more severe form of the illness, characterized by high fever, jaundice (yellowing of the skin and eyes), vomiting, bleeding, organ failure, and shock. The mortality rate for those progressing to this severe phase is around 50%, with death occurring within seven to ten days. The incubation period for yellow fever ranges from three to six days, according to the World Health Organization.
The National Institutes of Health in the United States reports that severe cases can lead to liver, kidney failure, and severe hemorrhaging. There is currently no specific antiviral treatment for yellow fever; care focuses on managing symptoms and preventing complications.
WHO Recommendations and Prevention
In response to the escalating situation, the WHO is urging member states to strengthen surveillance efforts, intensify vaccination campaigns targeting at-risk populations, and ensure that travelers to affected areas are adequately informed and protected. A key recommendation is maintaining a reserve stock of yellow fever vaccine to enable a rapid response to potential outbreaks. The WHO emphasizes the importance of a robust clinical management approach, focusing on early detection and treatment of severe cases. The organization notes that 27 countries in Africa and 13 in Latin America are classified as high-risk for yellow fever outbreaks, as detailed in a WHO fact sheet.
The PAHO also highlights the historical impact of yellow fever in the Americas, noting that large epidemics in the past disrupted economies and caused significant loss of life. Since 1970, the disease has resurfaced as a public health threat in the region, with outbreaks occurring in Argentina, Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Panama, Paraguay, Peru, Suriname, Trinidad and Tobago, and Venezuela. More information on the situation in the Americas can be found on the PAHO website.
Looking Ahead
The recent increase in yellow fever cases across the Americas demands a sustained and coordinated response. Continued monitoring of the situation, coupled with proactive vaccination strategies and enhanced public health infrastructure, will be crucial in mitigating the risk of further outbreaks and protecting vulnerable populations. The WHO’s call for increased preparedness underscores the importance of a global approach to combating this preventable disease.
Share this information with your network to raise awareness about the risks of yellow fever and the importance of preventative measures. Your comments and questions are welcome below.
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
